The risk increase for death may, as an example, be mediated by unhealthy fat distribution, independent of insulin levels, that is associated with higher GIP release, or by promotion of obesity [35, 36]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.